An initiative to improve primary prevention of cardiovascular disease in adults with type II diabetes based on the ACC/AHA (2013) and ADA (2016) guidelines

Abstract

Purpose This project was designed to increase family practice clinicians’ adherence to the American College of Cardiology/American Heart Association (2013) and American Diabetes Association (ADA, 2016) clinical practice guidelines for the prevention of cardiovascular disease (CVD) in 40‐ to 75‐year‐old adults with type II diabetes (DMII) through interactive education, an electronic alert, and quality improvement sessions on the treatment and management of cholesterol in a family practice primary care setting. Data sources A pre‐ and postretrospective chart review of 159 charts from a family practice clinic was conducted. Included in the chart review were 40‐ to 75‐year‐olds with a diagnosis of DMII. Conclusions Three outcomes were analyzed. Assessment of Atherosclerotic Cardiovascular Disease risk score increased from 0% to 76.7% (X2 (1, 159) = 93.46, p < .001), diet and exercise counseling documentation increased from 85% to 100%, and statin therapy application increased from 55.1% to 72.2% (X2 (1, 159) = 11.55, p = .003) in eligible adults 40–75 years‐old with DMII. Implications for practice This initiative helps to build the body of evidence regarding useful interventions to improve primary prevention of CVD by improving clinician adherence to the clinical care guidelines for 40‐ to 75‐year‐old adults with DMII.

Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka

“…10 Therefore, professional organizations have advocated multipronged approach by recommending optimal therapeutic targets for major CVD risk factors in order to combat rising incidence CVD morbidity and mortality among patients with diabetes. 11 However, many studies conducted in different settings mentioned subsequently reveal disappointing results with regard to the proportion of patients achieving recommended therapeutic goals in the aforementioned risk factors.…”

Adipose tissue–derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases

“…Hyperlipidaemia and hypertension were defined according to the latest European Society Cardiology Guidelines (35,36). Diabetes mellitus was defined according to the American Diabetes Association guidelines (37). Obesity was defined according to the Adult Treatment Panel (ATP) III guidelines (38).…”

Association of Self-Reported Dietary and Drug Compliance with Optimal Metabolic Control in Patients with Type 2 Diabetes: Clinic-Based Single-Center Study in a Developing Country

“…Findings of these studies emphasize that intensive control of not only blood glucose but also adverse lipids such as low-density lipoproteins (LDLs) and blood pressure is necessary to reduce the micro- and macrovascular complications of diabetes. Based on those studies, professional organizations have laid down the optimal levels of blood glucose, blood pressure, and adverse lipids that should be achieved in order to prevent and delay the onset of major complications of diabetes [ 4 , 5 ].…”